版本:
中国

BRIEF-Biotest ‍sells US therapy business to Adma Biologics, Inc.​

June 7 BIOTEST AG:

* ‍SOLD US THERAPY BUSINESS TO ADMA BIOLOGICS, INC.​

* ‍RECEIVES 50% MINUS ONE SHARE OF ADMA​

* ‍RECEIVES ALSO DISTRIBUTION RIGHTS OF SPECIFIED CURRENT PRODUCT AND A RIGHT OF FIRST OFFER FOR DISTRIBUTION OF FUTURE PRODUCTS OF ADMA FOR EUROPE, NEAR AND MIDDLE EAST AND SELECTED ASIAN COUNTRIES​

* ‍AS PART OF TRANSACTION, BIOTEST HAS CONTRIBUTED EUR11.5 MILLION IN CASH AS WELL AS A EUR14 MILLION LOAN​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐